Latest Insider Transactions at Lmf Acquisition Opportunities Inc (LMAO)
This section provides a real-time view of insider transactions for Lmf Acquisition Opportunities Inc (LMAO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LMF Acquisition Opportunities Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LMF Acquisition Opportunities Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 12
2024
|
David A Green Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
752,500
+50.0%
|
-
|
|
Apr 12
2024
|
Rick Barnett |
BUY
Grant, award, or other acquisition
|
Direct |
70,264
+44.77%
|
-
|
|
Apr 12
2024
|
Andres Lobo |
BUY
Grant, award, or other acquisition
|
Direct |
32,322
+44.51%
|
-
|
|
Apr 12
2024
|
Richard D. Russell |
BUY
Grant, award, or other acquisition
|
Direct |
32,322
+34.9%
|
-
|
|
Apr 12
2024
|
Allan Collins |
BUY
Grant, award, or other acquisition
|
Direct |
37,943
+41.11%
|
-
|
|
Apr 12
2024
|
Kenneth Van Heel |
BUY
Grant, award, or other acquisition
|
Direct |
43,564
+21.4%
|
-
|
|
Apr 12
2024
|
Bruce M. Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
36,537
+45.08%
|
-
|
|
Nov 29
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
20,293
+12.67%
|
-
|
|
Nov 29
2023
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,422
+23.12%
|
-
|
|
Nov 29
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,248
+6.71%
|
-
|
|
Nov 22
2023
|
Kenneth Van Heel |
BUY
Open market or private purchase
|
Direct |
100,000
+46.21%
|
$0
$0.4 P/Share
|
|
Sep 22
2023
|
Caryl Baron Interim CFO |
BUY
Other acquisition or disposition
|
Direct |
15,070
+11.19%
|
-
|
|
Sep 15
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,109
+5.01%
|
-
|
|
Sep 15
2023
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,257
+18.15%
|
-
|
|
Sep 15
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,110
+3.78%
|
-
|
|
Aug 31
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,374
+3.25%
|
-
|
|
Aug 31
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,178
+4.55%
|
-
|
|
Aug 31
2023
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,178
+22.64%
|
-
|
|
Aug 15
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,031
+2.05%
|
-
|
|
Aug 15
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,176
+2.92%
|
-
|
|
Aug 15
2023
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,930
+16.6%
|
-
|
|
Jun 23
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
417,386
+37.95%
|
-
|
|
Jun 09
2023
|
Caryl Baron Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,070
-13.69%
|
$0
$0.53 P/Share
|
|
Jun 09
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
56,869
+34.07%
|
-
|
|
May 30
2023
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
12,543
+4.64%
|
$0
$0.48 P/Share
|
|
May 25
2023
|
Richard D. Russell |
BUY
Open market or private purchase
|
Direct |
20,000
+41.69%
|
$0
$0.5 P/Share
|
|
May 18
2023
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,500
+11.89%
|
$0
$0.7 P/Share
|
|
Apr 06
2023
|
Rick Barnett |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+32.73%
|
-
|
|
Apr 06
2023
|
Kenneth Van Heel |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+32.73%
|
-
|
|
Apr 06
2023
|
Allan Collins |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+32.73%
|
-
|
|
Apr 06
2023
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,483
+20.06%
|
-
|
|
Apr 06
2023
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
11,080
+17.24%
|
-
|
|
Apr 06
2023
|
Bruce M. Rodgers |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+50.0%
|
-
|
|
Apr 06
2023
|
Richard D. Russell |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+50.0%
|
-
|
|
Apr 06
2023
|
Andres Lobo |
BUY
Grant, award, or other acquisition
|
Direct |
7,978
+50.0%
|
-
|
|
Oct 28
2022
|
Dow Employees' Pension Plan Trust > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+6.32%
|
-
|
|
Oct 28
2022
|
Dow Employees' Pension Plan Trust > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
4,149,841
+50.0%
|
-
|
|
Oct 28
2022
|
Union Carbide Employees' Pension Plan Trust > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+6.32%
|
-
|
|
Oct 28
2022
|
Union Carbide Employees' Pension Plan Trust > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
2,766,555
+50.0%
|
-
|
|
Oct 28
2022
|
Rick Barnett |
BUY
Grant, award, or other acquisition
|
Direct |
8,422
+50.0%
|
-
|
|
Oct 28
2022
|
Eric Schlorff Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,530
+50.0%
|
-
|
|
Oct 28
2022
|
Allan Collins |
BUY
Grant, award, or other acquisition
|
Direct |
8,422
+50.0%
|
-
|
|
Oct 28
2022
|
Kenneth Van Heel |
BUY
Grant, award, or other acquisition
|
Direct |
8,422
+50.0%
|
-
|
|
Oct 28
2022
|
Caryl Baron Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,112
+50.0%
|
-
|
|
Oct 28
2022
|
Lmfao Sponsor, LLC > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Direct |
2,587,500
+50.0%
|
-
|
|
Oct 28
2022
|
Lm Funding America, Inc. > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,587,500
+50.0%
|
-
|
|
Apr 06
2022
|
Kevin Chung Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,322
+47.97%
|
-
|
|
Apr 05
2022
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,760
+50.0%
|
$3,760
$1.85 P/Share
|